HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Mistrík Selected Research

Multiple Myeloma

5/2021Real-world effectiveness and safety of daratumumab, bortezomib and dexamethasone in relapsed/refractory multiple myeloma in Slovakia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Mistrík Research Topics

Disease

3Neoplasms (Cancer)
12/2023 - 04/2011
1Genomic Instability
01/2022
1Multiple Myeloma
05/2021
1Inborn Errors Metabolism (Inborn Errors of Metabolism)
07/2017
1Ornithine Carbamoyltransferase Deficiency Disease
07/2017
1Mitochondrial Diseases (Mitochondrial Disease)
11/2014
1Melanoma (Melanoma, Malignant)
11/2014

Drug/Important Bio-Agent (IBA)

1CopperIBA
12/2023
1Protein Isoforms (Isoforms)IBA
01/2022
1Dexamethasone (Maxidex)FDA LinkGeneric
05/2021
1daratumumabIBA
05/2021
1Bortezomib (Velcade)FDA Link
05/2021
1DNA (Deoxyribonucleic Acid)IBA
10/2017
1EnzymesIBA
07/2017
1Ornithine Carbamoyltransferase (Ornithine Transcarbamylase)IBA
07/2017
1Urea (Carbamide)FDA LinkGeneric
07/2017
1Superoxides (Superoxide)IBA
11/2014
1Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2014
1Aspartic Acid (Aspartate)FDA Link
11/2014
1pyrimidineIBA
04/2011
1Cyclin-Dependent Kinases (cdk Proteins)IBA
04/2011
1RoscovitineIBA
04/2011

Therapy/Procedure

2Therapeutics
10/2017 - 04/2011
1Drug Therapy (Chemotherapy)
10/2017